Sartorius Stedim Biotech SA (SDMHF)
217.09
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Sartorius Stedim Biotech EPS Diluted (Quarterly) : 1.111 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.111 |
| March 31, 2026 | 1.059 |
| December 31, 2025 | 0.5658 |
| September 30, 2025 | 0.7711 |
| June 30, 2025 | 0.7986 |
| March 31, 2025 | 0.9259 |
| December 31, 2024 | 0.4999 |
| September 30, 2024 | 0.2879 |
| June 30, 2024 | 0.5266 |
| March 31, 2024 | 0.6295 |
| December 31, 2023 | 0.3698 |
| September 30, 2023 | 0.406 |
| June 30, 2023 | 1.572 |
| March 31, 2023 | 1.293 |
| December 31, 2022 | 2.066 |
| September 30, 2022 | 2.192 |
| June 30, 2022 | 2.48 |
| March 31, 2022 | 3.287 |
| December 31, 2021 | 0.1018 |
| September 30, 2021 | 1.889 |
| June 30, 2021 | 1.941 |
| March 31, 2021 | 1.644 |
| December 31, 2020 | 1.229 |
| September 30, 2020 | 1.265 |
| June 30, 2020 | 0.8064 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8976 |
| December 31, 2019 | 0.6606 |
| September 30, 2019 | 0.7056 |
| June 30, 2019 | 0.7899 |
| March 31, 2019 | 0.6911 |
| December 31, 2018 | 0.8375 |
| September 30, 2018 | 0.6233 |
| June 30, 2018 | 0.6431 |
| March 31, 2018 | 0.5408 |
| December 31, 2017 | 0.5651 |
| September 30, 2017 | 0.4749 |
| June 30, 2017 | 0.4622 |
| March 31, 2017 | 0.4583 |
| December 31, 2016 | 0.3987 |
| September 30, 2016 | 0.5246 |
| June 30, 2016 | 0.4855 |
| March 31, 2016 | 0.4355 |
| December 31, 2015 | 0.2973 |
| September 30, 2015 | 0.4909 |
| June 30, 2015 | 0.3924 |
| March 31, 2015 | 0.2286 |
| December 31, 2014 | 0.2498 |
| September 30, 2014 | 0.2826 |
| June 30, 2014 | 0.2788 |
| March 31, 2014 | 0.2306 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Azenta, Inc. | 0.0542 |
| Danaher Corp. | 1.230 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.95M |
| Revenue (Quarterly) | 890.29M |
| Total Expenses (Quarterly) | 782.15M |
| Enterprise Value | 23.65B |
| Gross Profit Margin (Quarterly) | 46.86% |
| Profit Margin (Quarterly) | 12.24% |
| Earnings Yield | 1.62% |
| Operating Earnings Yield | 3.08% |
| Normalized Earnings Yield | 1.886 |